Frank Rimerman Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.88M Sell
19,895
-14
-0.1% -$4.16K 0.39% 40
2025
Q4
$5.44M Buy
19,909
+1,574
+9% +$428K 0.34% 46
2025
Q3
$4.95M Buy
18,335
+1,382
+8% +$376K 0.32% 48
2025
Q2
$4.67M Buy
16,953
+1,794
+12% +$488K 0.31% 50
2025
Q1
$4.02M Sell
15,159
-1,481
-9% -$365K 0.32% 47
2024
Q4
$3.86M Buy
16,640
+1,743
+12% +$401K 0.28% 53
2024
Q3
$3.29M Sell
14,897
-5,252
-26% -$1.09M 0.23% 67
2024
Q2
$3.96M Buy
20,149
+20,135
+143,821% +$4.16M 0.28% 53
2024
Q1
$3.01K Hold
14
﹤0.01% 252
2023
Q4
$2.95K Buy
+14
New +$2.99K ﹤0.01% 234

Other funds holding CME

Frank Rimerman Advisors's CME Position: Q1 2026 in Review

Frank Rimerman Advisors reduced its CME Group (CME) stake by 0.07% in Q1 2026, selling an estimated $4.16K and leaving 19,895 shares worth $5.88M. The position accounts for 0.39% of the portfolio, ranked #40.

Frank Rimerman Advisors first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Frank Rimerman Advisors held 19,895 shares of CME Group worth $5.88M as of Q1 2026.
  • Frank Rimerman Advisors sold 14 CME Group shares in Q1 2026, an estimated $4.16K.
  • CME Group made up 0.39% of Frank Rimerman Advisors's portfolio in Q1 2026, its #40 holding.
  • Frank Rimerman Advisors first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.